1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Generic Name | Common Trade Name(s) | Classification | Date Marketed in Canada (yyyy/mm/dd) |
---|---|---|---|
Doravirine + Lamivudine + Tenofovir | Delstrigo | Antiviral agent | 2018/12/15 |
Doripenem | Doribax | Antibacterial agent | 2009/09 |
Doxepin | Silenor | Hypnotic | 2012/01/08 |
Dronabinol | Marinol | Antiemetic | 2012/02/24 |
Dronedarone | Multaq | Antiarrhythmic agent | 2009/08/14 |
Drospirenone + estetrol | Nextstellis | Oral contraceptive | 2021/06/15 |
Drotrecogin alfa | Xigris | Antithrombotic profibrinolytic anti-inflammatory enzyme | 2011/10/25 |
Dulaglutide | Trulicity | Antihyperglycemic agent | 2016/01/08 |
Dupilumab | Dupixent | Skin and mucous membrane agent | 2017/11/30 |
Dutasteride + tamsulosin | Jalyn | Alpha-1 blocker + 5-Alpha reductase inhibitor | 2012/02/03 |
Eculizumab | Soliris | Humanized monoclonal antibody | 2009/06/29 |
Edaravone | Radicava | Treatment for amyotrophic lateral sclerosis | 2019/10/29 |
Edoxaban | Lixiana | Anticoagulant | 2017/01 |
Elagolix | Orilissa | Gonadotropin releasing hormone receptor antagonist | 2018/10/31 |
Elbasvir + grazoprevir | Zepatier | Antiviral agent | 2016/02/02 |
Elexacaftor + tezacaftor + ivacaftor | Trikafta | Cystic fibrosis transmembrane conductance regulator correctors | 2021/06/22 |
Eltrombopag | Revolade | Thrombopoietin receptor antagonist | 2011/0404 |
Eluxadoline | Viberzi | Miscellaneous GI drug | 2017/05 |
Eluxadoline | Viberzi | Miscellaneous GI drugs | 2017/04/24 |
Elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide | Genvoya | Antiretroviral agents | 2016/02/03 |
Elvitegravir + Cobicistat + Emtricitabine + Tenofovir disoproxil fumarate | Stribild | Antiretroviral agent | 2012/12/20 |
Empagliflozin | Jardiance | Sodium-glucose contransporter 2 (SGLT2) inhibitor | 2015/08/11 |
Empagliflozin + linagliptin | Glyxambi | Antidiabetic agent | 2016/12/15 |
Empagliflozin + metformin | Synjardy | Oral blood glucose lowering agents | 2017/09/18 |
Emtricitabine + tenofovir | Descovy | Antiretroviral agent | 2016/06/03 |
Enasidenib | IDHIFA | Antineoplastic agent / IDH2 Inhibitor | 2019/02/27 |
Entrectinib | Rozlytrek | Antineoplastic agent | |
Enzalutamide | Xtandi | Antineoplastic agent | 2013/06/07 |
Eplerenone | Inspra | Aldosterone antagonist | 2009/02/26 |
Eptinezumab | Vyepti | Prevention of migraine; calcitonin gene-related peptide binding antibody | 2021/01/11 |
Erdafitinib | Balversa | Protein kinase inhibitor | 2019/12/09 |
Erenumab | Aimovig | Anti-calcitonin gene-related peptide receptor | 2018/08/01 |
Eribulin | Halaven | Antineoplastic agent | 2012/03/10 |
Ertugliflozin | Steglatro | Sodium-glucose co-transporter 2 (SGLT2) inhibitor | 2018/05/23 |
Ertugliflozin + metformin | Segluromet | Oral blood glucose lowering agents | 2018/05/30 |
Ertugliflozin + sitagliptin | Steglujan | Oral blood glucose lowering agents | 2018/05/22 |